Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioDelivery Sciences International (World wide rights to Onsolis drug)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of cancer drugs. The company develops drugs and medicinal cures for treatment of cancer and other serious diseases.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Acquirer
Primary Office
  • United States

BioDelivery Sciences International (World wide rights to Onsolis drug) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioDelivery Sciences International (World wide rights to Onsolis drug)‘s full profile, request access.

Request full access to PitchBook

BioDelivery Sciences International (World wide rights to Onsolis drug) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore BioDelivery Sciences International (World wide rights to Onsolis drug)‘s full profile, request access.

Request full access to PitchBook